Potential impact of the MFN model on innovative medicine
While the content of the deals are not public, the White House has announced that each agreement includes language that manufacturers guarantee MFN pricing for...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
While the content of the deals are not public, the White House has announced that each agreement includes language that manufacturers guarantee MFN pricing for...
Given that average launch prices for orphan drugs are seven times higher than those of non-orphan drugs, and with an estimated 1 in 10 Americans affected by a...
CRA is a proud sponsor of the summit. Simon Chisholm is a speaker during the session titled “Understanding Lessons and Takeaways from Market Investigations”...
CRA is a proud sponsor of the conference dedicated to providing invaluable opportunities for networking and collaboration with the chance to meet, engage with...
